• Reported GAAP EPS of -$0.04 up 63.64% YoY • Reported revenue of $56.35M up 15.00% YoY • SI-BONE projects 2026 worldwide revenue between $228.5M and $232.5M, implying 14% to 16% year-over-year growth, with gross margin around 78% and operating expenses growth of ~12.5%.
Bullish
SI-BONE achieved strong Q4 2025 worldwide revenue growth of 15.0% to $56.3M and a 176.2% adjusted EBITDA improvement. The company also expanded its INTRA platform and formed a strategic distribution partnership.
Bearish
SI-BONE faced increased operating expenses of $47M in Q4 2025, resulting in a net loss of -$1.6M. The company also faces supply chain risks and future capital requirements for new surgical systems.